| MORC2 mutations cause axonal Charcot–Marie–Tooth disease with pyramidal signs OM Albulym, ML Kennerson, MB Harms, AP Drew, AH Siddell, ... Annals of neurology 79 (3), 419-427, 2016 | 53 | 2016 |
| Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach HA Alghamdi, SA Attique, W Yan, A Arooj, O Albulym, D Zhu, M Bilal, ... Process Biochemistry 110, 216-222, 2021 | 23 | 2021 |
| Antimicrobial activity of Ga-doped hydroxyapatite nanostructures: synthesis, morphological, spectroscopic, and dielectric properties O Albulym, O Kaygili, MSA Hussien, HY Zahran, M Kilany, IS Yahia, ... Journal of Biomaterials and Tissue Engineering 9 (7), 881-889, 2019 | 7 | 2019 |
| 5-minute synthesis of gelatinous silver nanoparticles using microwave radiation: Plasmonic optical spectroscopy and antimicrobial activity O Albulym, MSA Hussien, M Kilany, HY Zahran, RA Eid, IS Yahia, ... Optik 228, 166139, 2021 | 6 | 2021 |
| The MFN2 V705I Variant Is Not a Disease‐Causing Mutation: A Segregation Analysis in a CMT2 Family OM Albulym, D Zhu, S Reddel, M Kennerson, G Nicholson Journal of neurodegenerative diseases 2013 (1), 495873, 2013 | 5 | 2013 |
| Facile microwave synthesis of silver nanoplates: optical plasmonic and antimicrobial activity HY Zahran, M Kilany, IS Yahia, O Albulym, MSA Hussien, MM Abutalib Materials Research Express 6 (9), 095073, 2019 | 3 | 2019 |
| Synthesis and Characterization of Yttrium-Doped Hydroxyapatite Nanoparticles and Their Potential Antimicrobial Activity O Albulym, O Kaygili, MSA Hussien, HY Zahran, M Kilany, R Darwish, ... Journal of Biomaterials and Tissue Engineering 11 (11), 2087-2096, 2021 | 2 | 2021 |
| Green synthesis, structural, in vitro and in vivo bioactivity properties of ZnO nanoparticles for biomedical applications EH Ibrahim, O Albulym, O Kaygili, M Kilany, M Shkir, MSA Hussien, ... Journal of Biomaterials and Tissue Engineering 9 (6), 731-738, 2019 | 2 | 2019 |
| Biallelic loss of function variant in ZNF808 is associated with non-syndromic neonatal diabetes MA Alqahtani, SM Al-Qahtani, YH Al-Falki, E Alharby, OM Albulym, ... Clinical Genetics 104 (4), 497-498, 2023 | | 2023 |
| Refractory Status Epilepticus as the First Presentation in an Infant with Alpers Disease SM Al-Qahtani, IAAZ Asiri, OM Albulym, MY Otaif Bahrain Medical Bulletin 43 (4), 2021 | | 2021 |
| Investigating the functional consequences of Microrchidia 2 (MORC2) mutations causing axonal CMT (CMT2Z) A Siddell, O Albulym, G Perez-Siles, MH Brewer, GA Nicholson, ... Journal of the Peripheral Nervous System 21 (3), 300-300, 2016 | | 2016 |
| Clinical Study The MFN2 V705I Variant Is Not a Disease-Causing Mutation: A Segregation Analysis in a CMT2 Family OM Albulym, D Zhu, S Reddel, M Kennerson, G Nicholson | | 2013 |
